Bulletin
Investor Alert

Market Pulse Archives

Oct. 27, 2021, 8:48 a.m. EDT

Novavax is seeking authorization in the U.K. for its COVID-19 vaccine

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Novavax Inc. (NVAX)
  • X
    BioNTech SE ADR (BNTX)
  • X
    Pfizer Inc. (PFE)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -0.92% jumped 8.0% in premarket trading on Wednesday after the company said it began submitting its experimental COVID-19 vaccine for authorization in the U.K. Novavax's vaccine candidate is protein-based, meaning it's a different type of vaccine than the mRNA shots developed by BioNTech SE /zigman2/quotes/214419716/composite BNTX +3.17% /Pfizer Inc. /zigman2/quotes/202877789/composite PFE +2.32% and Moderna Inc. /zigman2/quotes/205619834/composite MRNA +1.73% or the ChAdOx1 technology used in the AstraZeneca /zigman2/quotes/200304487/composite AZN -1.02% shots. Novavax's vaccine came out of clinical trials in the U.K. with an overall efficacy rate of 89.7%. The company plans to submit its vaccine candidate to U.S. regulators by the end of the year. Novavax's stock is up 21.0% for the year, while the S&P 500 /zigman2/quotes/210599714/realtime SPX -0.84% has gained 21.8%.

/zigman2/quotes/202614340/composite
US : U.S.: Nasdaq
$ 160.48
-1.49 -0.92%
Volume: 4.51M
Dec. 3, 2021 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$12.25 billion
Rev. per Employee
$601,262
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 344.06
+10.57 +3.17%
Volume: 3.33M
Dec. 3, 2021 4:00p
P/E Ratio
9.93
Dividend Yield
N/A
Market Cap
$80.88 billion
Rev. per Employee
$283,276
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 54.27
+1.23 +2.32%
Volume: 37.57M
Dec. 3, 2021 4:02p
P/E Ratio
16.11
Dividend Yield
2.87%
Market Cap
$297.71 billion
Rev. per Employee
$533,860
loading...
/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 306.72
+5.23 +1.73%
Volume: 12.70M
Dec. 3, 2021 4:00p
P/E Ratio
18.84
Dividend Yield
N/A
Market Cap
$122.24 billion
Rev. per Employee
$617,996
loading...
/zigman2/quotes/200304487/composite
US : U.S.: Nasdaq
$ 54.23
-0.56 -1.02%
Volume: 5.75M
Dec. 3, 2021 4:00p
P/E Ratio
85.59
Dividend Yield
2.53%
Market Cap
$169.69 billion
Rev. per Employee
$362,602
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,538.43
-38.67 -0.84%
Volume: 2.71B
Dec. 3, 2021 5:35p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.